Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free divalent and trivalent metal ions in solution are essential inorganic components that serve as critical cofactors for enzymes and structural elements for proteins (StatPearls, 2023). While ions such as calcium, magnesium, and iron are vital for physiological processes like signaling and oxygen transport, their unbound or "free" forms can become highly toxic when concentrations exceed the body's buffering capacity (NIH, 2023). Pathological accumulation occurs in conditions like hereditary hemochromatosis (iron), Wilson's disease (copper), or through environmental exposure to heavy metals like lead and mercury (National Institute of Environmental Health Sciences, 2023). These ions promote oxidative stress via Fenton-type reactions, damaging lipids, proteins, and DNA (PubMed, 2022). Therapeutic strategies involve the use of chelating agents, which are ligands designed to bind these metal ions with high affinity and specificity (PubChem, 2024). By forming stable, water-soluble complexes, these drugs prevent the ions from participating in toxic reactions and facilitate their excretion through the kidneys or bile (StatPearls, 2023). Consequently, targeting these ions is a cornerstone of treatment for metal poisoning and chronic mineral overload disorders.
Chelation therapy involves the administration of ligands that bind to free or loosely bound metal ions in the blood or tissues, forming stable, water-soluble complexes (chelates) that are subsequently excreted from the body via urine or bile (StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free divalent and trivalent metal ions in solution.